Mona Chitre, PharmD, CGP: Every social determinant of health has the impact and the potential to exacerbate MDD [major depressive disorder]. MDD and social determinants of health have a unique relationship. Social determinants of health can trigger mental health disorders, and mental health disorders can cause someone to make poor life decisions that trigger social determinants of health.
Let’s talk about social determinants of health. I often say it’s anything in your environment that can enable you to thrive, be well, or see a positive future. In the mental health arena, some pop up frequently. In no particular order, one is safe housing. Is there a safe housing option for our members? Are they in a safe community? Are they free of trauma and stress? Food and transportation are some basics. Do they know where their next meal is going to come from? Do they have access to a physician’s office or a pharmacy? Income level is another. Income level has many triggers toward health care disparities in general. It affects health care literacy, access to care, and access to treatment. Is their job secure? Is it a toxic environment? Is it safe? Family relationships [are another factor]. That’s just to name a few. Is there a family support group? Any social determinant of health can trigger a mental health challenge, a mental health crisis, or a mental health disorder.
Jay Weaver, PharmD, MPH: I have to agree with Dr Chitre. Most of the things she outlined were spot on. The only thing I’d add would be some of the nutritional challenges. We’re coming to understand that there’s a link between the foods that we eat and have access to and our sense of well-being. Things like high-calorie foods and high-carbohydrate foods are typically less expensive than higher-quality foods. We also know that the amounts of sugar and other things in those foods can affect our mental well-being. Sometimes food insecurity plays into major depressive disorder in ways that we don’t fully understand.
Transcript edited for clarity.
Social Determinants of Health in MDD: Part 2
Key social determinants of health impacting MDD are discussed by expert payer panelists.
EP: 1.Unmet Needs in Treatment of MDD
EP: 2.MDD Treatment Landscape
EP: 3.Potential Consequences of Recurrent or Poorly Controlled MDD
EP: 4.Burden of Treatment Failure in MDD
EP: 5.Importance of Early Effective Treatment of MDD
EP: 6.Evaluating MDD Treatment Attributes
EP: 7.Considerations for Newly Launched MDD Treatments
EP: 8.Healthcare Disparities Within Major Depressive Disorder
EP: 9.MDD Treatment Disparities Across Patient Populations
EP: 10.Social Determinants of Health in MDD
EP: 11.Impact of COVID-19 on Demand for Mental Health Services
EP: 12.Health Care Disparities Within Major Depressive Disorder (MDD)
EP: 13.MDD Treatment Disparities Across Patient Populations: Part 2
EP: 14.Social Determinants of Health in MDD: Part 2
EP: 15.Population Health Approach in MDD
EP: 16.Factors Affecting MDD Treatment Adherence
EP: 17.Supporting Adherence for Patients with MDD
EP: 18.Aligning MDD Treatment Goals for Payers and Patients
EP: 19.The Impact of Early Effective Treatment in MDD
EP: 20.Key Contributors to Long-term Outcomes for Patients With MDD
Mona Chitre, PharmD, CGP: Every social determinant of health has the impact and the potential to exacerbate MDD [major depressive disorder]. MDD and social determinants of health have a unique relationship. Social determinants of health can trigger mental health disorders, and mental health disorders can cause someone to make poor life decisions that trigger social determinants of health.
Let’s talk about social determinants of health. I often say it’s anything in your environment that can enable you to thrive, be well, or see a positive future. In the mental health arena, some pop up frequently. In no particular order, one is safe housing. Is there a safe housing option for our members? Are they in a safe community? Are they free of trauma and stress? Food and transportation are some basics. Do they know where their next meal is going to come from? Do they have access to a physician’s office or a pharmacy? Income level is another. Income level has many triggers toward health care disparities in general. It affects health care literacy, access to care, and access to treatment. Is their job secure? Is it a toxic environment? Is it safe? Family relationships [are another factor]. That’s just to name a few. Is there a family support group? Any social determinant of health can trigger a mental health challenge, a mental health crisis, or a mental health disorder.
Jay Weaver, PharmD, MPH: I have to agree with Dr Chitre. Most of the things she outlined were spot on. The only thing I’d add would be some of the nutritional challenges. We’re coming to understand that there’s a link between the foods that we eat and have access to and our sense of well-being. Things like high-calorie foods and high-carbohydrate foods are typically less expensive than higher-quality foods. We also know that the amounts of sugar and other things in those foods can affect our mental well-being. Sometimes food insecurity plays into major depressive disorder in ways that we don’t fully understand.
Transcript edited for clarity.
Patient/Physician Teamwork: Treating a Rare Oral Presentation of DLBCL
May 16th 2024A very unusual case of lip-based diffuse large B-cell lymphoma (DLBCL) was treated successfully thanks to prompt diagnosis and chemotherapy treatments.
Read More
Frameworks for Advancing Health Equity: Urban Health Outreach
May 9th 2024In the series debut episode of "Frameworks for Advancing Health Equity," Mary Sligh, CRNP, and Chelsea Chappars, of Allegheny Health Network, explain how the Urban Health Outreach program aims to improve health equity for individuals experiencing homelessness.
Listen
Cholesterol, Serum Markers of HS Improved With Switches to TAF Regimens
May 16th 2024Patients with HIV who switched to a treatment regimen that included tenofovir alafenamide (TAF) showed improvement in serum markers for hepatic steatosis (HS) among other benefits.
Read More
Updates on Adagrasib in CRC and the Importance of Genomic Testing With Dr Jun Gong
December 21st 2023Jun Gong, MD, of Cedars-Sinai Medical Center, discusses the latest data on adagrasib in colorectal cancer, the importance of conducting genomic testing, and more.
Listen
Corticosteroid Treatment Associated With Fast, Improved Outcomes in Patients With Sydenham Chorea
May 16th 2024Researchers compare treatments and outcomes in patients with Sydenham chorea, finding faster resolution with corticosteroid treatment.
Read More
FDA Grants Accelerated Approval for Liso-Cel for R/R Follicular Lymphoma
May 16th 2024FDA has given accelerated approval for lisocabtagene maraleucel (liso-cel; Breyanzi) for patients with relapsed or refractory (R/R) follicular lymphoma.
Read More
Patient/Physician Teamwork: Treating a Rare Oral Presentation of DLBCL
May 16th 2024A very unusual case of lip-based diffuse large B-cell lymphoma (DLBCL) was treated successfully thanks to prompt diagnosis and chemotherapy treatments.
Read More
Frameworks for Advancing Health Equity: Urban Health Outreach
May 9th 2024In the series debut episode of "Frameworks for Advancing Health Equity," Mary Sligh, CRNP, and Chelsea Chappars, of Allegheny Health Network, explain how the Urban Health Outreach program aims to improve health equity for individuals experiencing homelessness.
Listen
Cholesterol, Serum Markers of HS Improved With Switches to TAF Regimens
May 16th 2024Patients with HIV who switched to a treatment regimen that included tenofovir alafenamide (TAF) showed improvement in serum markers for hepatic steatosis (HS) among other benefits.
Read More
Updates on Adagrasib in CRC and the Importance of Genomic Testing With Dr Jun Gong
December 21st 2023Jun Gong, MD, of Cedars-Sinai Medical Center, discusses the latest data on adagrasib in colorectal cancer, the importance of conducting genomic testing, and more.
Listen
Corticosteroid Treatment Associated With Fast, Improved Outcomes in Patients With Sydenham Chorea
May 16th 2024Researchers compare treatments and outcomes in patients with Sydenham chorea, finding faster resolution with corticosteroid treatment.
Read More
FDA Grants Accelerated Approval for Liso-Cel for R/R Follicular Lymphoma
May 16th 2024FDA has given accelerated approval for lisocabtagene maraleucel (liso-cel; Breyanzi) for patients with relapsed or refractory (R/R) follicular lymphoma.
Read More